VIS-101 targets VEGF-A and ANG-2 with a bispecific tetravalent format designed to increase ligand affinity and binding capacity, aiming to improve anatomic/visual outcomes and extend dosing intervals.

GH Research PLC is rated a Buy with $280.7M in cash, supporting lead candidate GH001 for Treatment-Resistant Depression. Read more on GHRS stock here.

Spoilers are ahead from One Piece season 2 Episode 5! The fourth episode of One Piece season 2 saw the Straw Hats arrive at their second island on the Grand Lin ...

The FDA assigned a PDUFA target action date of December 22, 2026 - - The NDA is based on positive data from a successful clinical program demonstrating favorable safety and blood pressure reduction ...

The most consequential test of President Donald Trump’s crackdown on high-skilled immigration is arriving this month, as registration opens for the annual H-1B visa lottery under an entirely new set ...

All in all, the Wyoming Valley Conference fared quite well in the first round of the PIAA state basketball playoffs.

After four episodes of the most humane and genteel post-apocalyptic survival adventure you’re likely to come across, in which the one constant that binds people together is human kindness, along comes ...

In Paradise Season 2 Episode 5, Gary's growing affection for Xavier's wife Teri takes a dark turn, leading to unexpected ...

What is Paradise Season 2 Episode 5 about? Hulu/Disney. At the end of Episode 4, new character Gary claimed that Xavier’s ...

AVONDALE, Ariz. (AP) — Ryan Blaney completed a Team Penske sweep at Phoenix Raceway by winning the Cup Series race Sunday — a victory that denied Tyler Reddick a fourth consecutive win to start the ...

Data Reconstruction can be a confusing contract to take on at first in Marathon, but it can be completed fairly easily once you know what to do.

FDA IND clearance enables a phase 3 program evaluating TRIESENCE for postoperative ocular inflammation and pain following cataract surgery, aiming to broaden on-label use beyond current intraocular ...